Incidence GI tract toxicity is the most frequently irAE in patients treated by anti-CTLA-4 antibody causing to discontinuation of this drug [7,40]
not a drug or dietary supplement
The rate of first-time diagnoses increased with increasing overweight/obesity classes for T2D and sleep apnea
Be sure to check in with your patients regarding their progress
Then, in January 2025, she teamed up with the telehealth company Ro, which her husband, Alexis Ohanian, is an investor in and board member of, to receive Zepbound
When you combine targeted peptides with physician supervision, personalized dosing, and ongoing bloodwork monitoring, you create an environment where your body rebuilds muscle, sheds stubborn fat, and restores the hormonal balance that fuels confidence and vitality